market
chiral molecules
chirality of molecules
approach
chiral spectrum of molecules
pharmaceutical company
bio-chemistry
main fields
Business Plan
novel instrument
main goals
new spectrometer
fold reduction
new product
complete exploitation plan
indication
system
DNA
biochemistry research lab
biophysics labs
Fourier
D structural conformation of proteins
pharmaceutics
ultra-stable interferometer
secondary structure
thorough analysis
Technology Readiness Level
pharma industry
patent franchise
stability
external stimuli
patenting
footprint
version
important role
heterodyne amplification
ultimate maturity
safety
efficacy
quality
increased information content
strategic partners
profitability
mirror image
CHIMERA project
ones
Researchers
price
opportunity
prototypes
financing strategy
revolutionary device
right hands
aforementioned sectors
customers
ground-breaking concept
signal
forms
innovation potential
drugs
working prototype
advantages
proposal
TRL9
Spectrometers
object